Fundraising FoxBreakout Labs — Full Portfolio
14 tracked investments · listed companies and verified rows first
Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Ajay Shah(Co-founder & CEO)inHenry Tse(Co-founder & Chief Technology Officer)inDino DiCarlo(Director, Promoter)
BoardLindy Fishburne(Director)inJack Fuchs(Director, Promoter)in
Co-investorsAlumni VenturesBasecamp FundBlackhorn VenturesBreakout VenturesDolby Family VenturesEMV Capital+4 more
STRM.BIO develops technology to deliver gene therapies, aiming to improve how these treatments reach patients.
BiotechDeep TechHealthtechLongevityMedical Devices
Michael Luther(CEO)in
Co-investorsAscension VenturesBreakout VenturesDelos CapitalNYBC VenturesKdT Ventures
Hyperion Biosystems builds diagnostic devices that use computer vision and physics-based algorithms to improve the sensitivity and specificity of point-of-care and at-home tests.
AI & Machine LearningHealthtechMedical Devices
Co-investorsNewlin Investment Company LLCSafar PartnersBoston Millennia PartnersCranberry CapitalPropel Venture Partners
Ecovative grows whole-cut meat alternatives and leather-like materials from mycelium using its AirMycelium indoor cultivation platform, which integrates with existing mushroom farming infrastructure.
BiotechFoodTechNew MaterialsGreen Island, US
Eben Bayer(Cofounder)inGavin McIntyre(Cofounder)in
BoardEvan Lodes(Director)Jerry Weinstein(Director)Charles Deull(Director)Jessica Harris(Director)
Co-investorsBreakout VenturesCool Climate CollectiveStray Dog CapitalTrousdale VenturesAiiM PartnersFootPrint Coalition+2 more
Epana Bio develops therapies for autoimmune diseases by leveraging genomics and AI to identify and target cellular origins of disease, with a focus on precision medicine for patient populations.
AI & Machine LearningBiotechDigital Health
Co-investorsBreakout VenturesHAWKTAILHummingbird VenturesOMX VenturesKdT VenturesRefactor Capital
Glyscend Therapeutics is a clinical-stage biopharmaceutical company developing oral, first-in-class therapies for type 2 diabetes and obesity.
BiotechDeep TechDigital HealthHealthtechLongevityBaltimore, US
Ashish Nimgaonkar(Executive Officer, Director)Dennis McWilliams(Director)inCasey Cunningham(Director)Leighton Read(Director)inBob Soh(Director)in
Co-investorsBrandon BioCatalystBrandon Capital Partners
Immusoft develops a cell therapy platform called Immune System Programming (ISP) that engineers a patient's B cells into plasma cells that produce therapeutic proteins after being infused back into the patient.
BiotechDeep TechHealthtechSeattle, US
Matthew Scholz(Founder)inSean Ainsworth(Chief Executive Officer)inRobert Sikorski(Chief Medical Officer)Rob Hayes(Chief Scientific Officer)inScott McIvor(Chief Development Officer)Eric Garcia(Executive Officer)in
Co-investorsBioRock VenturesBoston Harbor AngelsBreakout VenturesEQx FundInvariantes FundMichigan Capital Network+5 more
Maxterial develops advanced chemicals and coatings, including a coating platform designed to protect surfaces against wear, heat, and corrosion.
Advanced ManufacturingDeep TechNew Materials
Co-investorsAnthropocene VenturesDellin InvestmentsHelios Climate VenturesIdeashipUP2398
Modern Meadow develops animal-free, bio-fabricated leather alternatives using synthetic biology and material science for the fashion, interiors, and automotive industries.
BiotechCircular EconomyNew MaterialsPine Brook, US
Gabor Forgacs(Founder)inFrancoise Marga(Founder)inKaroly Jakab(Founder)inAnna Bakst(Executive Officer, Director)inRex Liu(Executive Officer)David Williamson(CEO)in
Co-investorsArtis VenturesAstanor VenturesBreakout VenturesCollaborative FundHorizons VenturesInventus Capital Partners+5 more
Noetik builds AI models to identify cancer patients most likely to respond to treatments and to discover new oncology drug targets.
AI & Machine LearningBiotechHealthtechSouth San Francisco, US
Jacob Rinaldi(Executive Officer, Director, Promoter)inRonald Alfa(Executive Officer, Director, Promoter)Ron Alfa, MD, PhD(Co-Founder, CEO)in
BoardJames Hardiman(Director)inAmy Schulman(Director)
Co-investors11.2 CapitalBreakout VenturesCatalio Capital Management, LPEPIC VENTURESLinearis VenturesNorth South Ventures+5 more
Technology identifying supply chain sources using the environmental microbiome.
Co-investorsDolby Family VenturesGolden SeedsJ-VenturesWorking Capital FundAgFunderBlackhorn Ventures+4 more
Twelve transforms CO2 into chemicals, fuels, and materials through carbon transformation technology.
Advanced ManufacturingCleantechClimate TechHealthtechNew MaterialsMoses Lake, US
Nicholas Flanders(Founder & CEO)inEtosha Cave(Founder)inKendra Kuhl(Founder)inAndrew Cleeland(Executive Officer, Director)in
BoardMarc-Henri Galletti(Director)Nimesh Shah(Director)
Co-investorsBreakout VenturesDCVC (Data Collective)Dolby Family VenturesFifth WallAdvantage Partners Inc.Aera VC+31 more
ZymoChem develops bio-based materials using proprietary Carbon Conserving (C2) microbes that convert renewable feedstocks into high-value materials with increased yields.
BiotechCircular EconomyClimate TechNew MaterialsSan Leandro, US
Harshal Chokhawala(Founder & CEO)in
Co-investorsAccelr8Breakout VenturesCavallo VenturesDudley FundFreshTracks CapitalPrime Partners+7 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.